Faculty & Research

College of Basic Medicine -- LI Yingbo

Views:


 

PERSONAL INFORMATION

Name: Li Yingbo

Gender: Male

Title:associate professor

 

CONTACT INFORMATION

Email: liyingbo@cqmu.edu.cn

Address:  #1 Yixueyuan Road, Yu Zhong District, Chongqing, 400016, China

Phone: +86-18680835964

 

EDUCATION EXPERIENCE

1997.9 - 2002.7, Clinical Medicine, Bachelor, Three Gorges University

2002.9 - 2005.7, Physiology, Master, Chongqing Medical University

2007.9 - 2010.7, Tissue and Cell Engineering, PhD, Chongqing Medical University

 

WORKING EXPERIENCE

2010.7 to 2016.6, Lecturer, Department of Physiology, College of Basic Medical Sciences, Chongqing Medical University 

2016.7 to 2017.7, National Visiting Scholar, Lieber Institute for Brain Development, Johns Hopkins University

2016.9 to now, Associate professor, Department of Physiology, College of Basic Medical Sciences, Chongqing Medical University

2017.9 to now, Master's supervisor, Department of Physiology, College of Basic Medical Sciences, Chongqing Medical University

 

RESEARCH INTERESTS

Professor Li has been engaged in research on the Autism and Neuroscience. Current research interests: pathogenesis and drug treatment of autism. Professor Li has undertaken 3 projects of Chongqing Science and Technology Commission and 1 project of Chongqing Education Commission Scientific Research Project. He has participated in more than 10 projects of National Natural Science Foundation Commission, Chongqing Science and Technology Commission and Chongqing Education Commission. He has published 15 papers of SCI and CSCD Core journals as the first author or corresponding author, and has published more than 40 papers.

 

HONOUR & AWARDS

National College AI and Big Data Teaching Innovation Award

Outstanding Teacher of Chongqing Medical University

 

PUBLICATIONS

1. Yue Xiong, Jianhui Chen, Yingbo Li*.Microglia and astrocytes underlie neuroinflammation and synaptic susceptibility in autism spectrum disorder.Front Neurosci. 2023,17:1125428.

2. Yue Xiong, Jianhui Chen, Mingqi Lv, Feifei Wang, Hanhong Zhang, Boyi Tang, Yingbo Li*.Thymol improves autism-like behaviour in VPA-induced ASD rats through the Pin1/p38 MAPK pathway.Int Immunopharmacol. 2023,117:109885.

3. Man Xu, Luyi Wang, Yan Wang, Jing Deng, Xiaoya Wang, Feifei Wang, Sen Pan, Yu Zhao, Ailing Liao, Xiaoqing Wang, Di Chen, Jingjing Shen, Feng Yang, Yingbo Li*, Shali Wang*.Genes Brain Behav.2023,22(4):e12852.

4. Jing Wang#, Yingbo Li#, Chun-Mei Wan, Zong-Jie Gan, Lin-Ling Gan, Bai-Cheng He, Yu Yu, Xue-Lian Hu*.PTEN inhibition leads to the development of resistance to novel isoquinoline derivative TNBG-5602 in human liver cancer cells.Am J Cancer Res,2021,11(9):4515-4527.

5. Ming Ren, Zhonghua Hu, Qiang Chen, Andrew Jaffe, Yingbo Li, Vijay Sadashivaiah, Shujuan Zhu, Nina Rajpurohit, Joo Heon Shin, Wei Xia, Yankai Jia, Jingxian Wu, Sunny Lang Qin, Xinjian Li, Jian Zhu, Qingjun Tian, Daniel Paredes, Fengyu Zhang, Kuan Hong Wang, Venkata S Mattay, Joseph H Callicott, Karen F Berman, Daniel R Weinberger, Feng Yang*.KCNH2-3.1 mediates aberrant complement activation and impaired hippocampal-medial prefrontal circuitry associated with working memory deficits.Mol Psychiatry,2020,25(1):206-229.

6. Yan Wang, Xiaoqing Wang, Yingbo Li, Di Chen, Zhao Liu, Yu Zhao, Liu Tu, Shali Wang*.Regulation of progranulin expression and location by sortilin in oxygen-glucose deprivation/reoxygenation injury.Neurosci Lett.2020,1,738:135394.

7. Yingbo Li#, Yan Wang#, Liu Tu, Di Chen, Zhi Luo, Dengyuan Liu, Zhuang Miao, Gang Feng, Li Qing, Shali Wang*.Sub-Acute Toxicity Study of Graphene Oxide in the Sprague-Dawley Rat.Int J Environ Res Public Health.2016,17;13(11):1149.

8. Yingbo Li, Yan Wang, Ji-Ping Tang, Di Chen, Sha-Li Wang*.Neuroprotective effects of ginsenoside Rg1-induced neural stem cell transplantation on hypoxic-ischemic encephalopathy.Neural Regen Res,2015,10(5):753-9.

9. Yingbo Li, Jiping Tang, Nikan H Khatibi, Mei Zhu, Di Chen, Liu Tu, Li Chen, Shali Wang*.Treatment with ginsenoside rb1, a component of panax ginseng, provides neuroprotection in rats subjected to subarachnoid hemorrhage-induced brain injury.Acta Neurochir Suppl. 2011;110(Pt 2):75-9.

10. Yingbo Li, Jiping Tang, Nikan H Khatibi, Mei Zhu, Di Chen, Weiping Zheng, Shali Wang*.Ginsenoside Rbeta1 reduces neurologic damage, is anti-apoptotic, and down-regulates p53 and BAX in subarachnoid hemorrhage.Curr Neurovasc Res, 2010 ,7(2):85-94.